Endogenous metalloprotease solubilizes IL-13 receptor α2 in airway epithelial cells

Biochemical and Biophysical Research Communications

Volumn 360, Issue 2, 2007, Pages 464-469

  Matsumura, Mikiko ^a   Inoue, Hiromasa ^a   Matsumoto, Takafumi ^a   Nakano, Takako ^a   Fukuyama, Satoru ^a   Matsumoto, Koichiro ^a   Takayama, Koichi ^a   Saito, Makoto ^b   Kawakami, Koji ^c   Nakanishi, Yoichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Phorbol 12 myristate 13 acetate; Protease; Soluble receptor; Th2 cytokine

Indexed keywords

ADENOVIRUS VECTOR; APROTININ; BESTATIN; EOTAXIN; HEXACHLOROPHENE; ILOMASTAT; INTERLEUKIN 13 RECEPTOR ALPHA2; LEUPEPTIN; MEMBRANE RECEPTOR; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT INTERLEUKIN 13; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR;

ARTICLE; AUTOCRINE EFFECT; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RECEPTOR SOLUBILIZATION; RESPIRATORY EPITHELIUM; SIGNAL TRANSDUCTION; SUPERNATANT; UPREGULATION;

CELL LINE; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-13 RECEPTOR ALPHA2 SUBUNIT; METALLOPROTEASES; RESPIRATORY MUCOSA; SOLUBILITY; TETRADECANOYLPHORBOL ACETATE;

EID: 34447103212     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.076     Document Type: Article

References (32)

1. Grunig G., Warnock M., Wakil A.E., Venkayya R., Brombacher F., Rennick D.M., Sheppard D., Mohrs M., Donaldson D.D., Locksley R.M., and Corry D.B. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282 (1998) 2261-2263
2. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T.Y., Karp C.L., and Donaldson D.D. Interleukin-13: central mediator of allergic asthma. Science 282 (1998) 2258-2261
3. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., Zhang Y., and Elias J.A. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103 (1999) 779-788
4. Aman M.J., Tayebi N., Obiri N.I., Puri R.K., Modi W.S., and Leonard W.J. cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J. Biol. Chem. 271 (1996) 29265-29270
5. Hilton D.J., Zhang J.G., Metcalf D., Alexander W.S., Nicola N.A., and Willson T.A. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 93 (1996) 497-501
6. Miloux B., Laurent P., Bonnin O., Lupker J., Caput D., Vita N., and Ferrara P. Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex. FEBS Lett. 401 (1997) 163-166
7. Caput D., Laurent P., Kaghad M., Lelias J.M., Lefort S., Vita N., and Ferrara P. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J. Biol. Chem. 271 (1996) 16921-16926
8. Donaldson D.D., Whitters M.J., Fitz L.J., Neben T.Y., Finnerty H., Henderson S.L., O'Hara Jr. R.M., Beier D.R., Turner K.J., Wood C.R., and Collins M. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J. Immunol. 161 (1998) 2317-2324
9. Kawakami K., Taguchi J., Murata T., and Puri R.K. The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway. Blood 97 (2001) 2673-2679
10. Kawakami K., Takeshita F., and Puri R.K. Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain. J. Biol. Chem. 276 (2001) 25114-25120
11. Chiaramonte M.G., Mentink-Kane M., Jacobson B.A., Cheever A.W., Whitters M.J., Goad M.E., Wong A., Collins M., Donaldson D.D., Grusby M.J., and Wynn T.A. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J. Exp. Med. 197 (2003) 687-701
12. Wood N., Whitters M.J., Jacobson B.A., Witek J., Sypek J.P., Kasaian M., Eppihimer M.J., Unger M., Tanaka T., Goldman S.J., Collins M., Donaldson D.D., and Grusby M.J. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J. Exp. Med. 197 (2003) 703-709
13. Fichtner-Feigl S., Strober W., Kawakami K., Puri R.K., and Kitani A. IL-13 signaling through the IL-13alpha(2) receptor is involved in induction of TGF-beta(1) production and fibrosis. Nat. Med. (2005)
14. Daines M.O., and Hershey G.K. A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha -2 and their rapid mobilization by interferon-gamma. J. Biol. Chem. 277 (2002) 10387-10393
15. Kioi M., Seetharam S., and Puri R.K. N-linked glycosylation of IL-13R alpha2 is essential for optimal IL-13 inhibitory activity. FASEB J. 20 (2006) 2378-2380
16. Levine S.J. Mechanisms of soluble cytokine receptor generation. J. Immunol. 173 (2004) 5343-5348
17. Nishizuka Y. Studies and perspectives of protein kinase C. Science 233 (1986) 305-312
18. Saito M., Murata T., Watanabe K., Kawakami K., Suzuki M., Koji T., Puri R.K., Kitazato K., and Kobayashi N. Adenoviral vector-mediated gene transfer of IL-13Ralpha2 chain followed by IL-13 cytotoxin treatment offers potent targeted therapy for cytotoxin-resistant cancers. Int. J. Cancer 116 (2005) 1-8
19. Nakano T., Inoue H., Fukuyama S., Matsumoto K., Matsumura M., Tsuda M., Matsumoto T., Aizawa H., and Nakanishi Y. Niflumic acid suppresses interleukin-13-induced asthma phenotypes. Am. J. Respir. Crit. Care Med. 173 (2006) 1216-1221
20. Inoue H., Kato R., Fukuyama S., Nonami A., Taniguchi K., Matsumoto K., Nakano T., Tsuda M., Matsumura M., Kubo M., Ishikawa F., Moon B.G., Takatsu K., Nakanishi Y., and Yoshimura A. Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness. J. Exp. Med. 201 (2005) 73-82
21. Hoeck J., and Woisetschlager M. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts. J. Immunol. 166 (2001) 4507-4515
22. Matsukura S., Stellato C., Georas S.N., Casolaro V., Plitt J.R., Miura K., Kurosawa S., Schindler U., and Schleimer R.P. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a stat6-dependent mechanism. Am. J. Respir. Cell Mol. Biol. 24 (2001) 755-761
23. Bernard J., Treton D., Vermot-Desroches C., Boden C., Horellou P., Angevin E., Galanaud P., Wijdenes J., and Richard Y. Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL-13Ralpha2 as a decoy receptor for IL-13. Lab Invest. 81 (2001) 1223-1231
24. Arribas J., and Borroto A. Protein ectodomain shedding. Chem. Rev. 102 (2002) 4627-4638
25. Hooper N.M., Karran E.H., and Turner A.J. Membrane protein secretases. Biochem. J. 321 Pt 2 (1997) 265-279
26. Peschon J.J., Slack J.L., Reddy P., Stocking K.L., Sunnarborg S.W., Lee D.C., Russell W.E., Castner B.J., Johnson R.S., Fitzner J.N., Boyce R.W., Nelson N., Kozlosky C.J., Wolfson M.F., Rauch C.T., Cerretti D.P., Paxton R.J., March C.J., and Black R.A. An essential role for ectodomain shedding in mammalian development. Science 282 (1998) 1281-1284
27. King N.E., Zimmermann N., Pope S.M., Fulkerson P.C., Nikolaidis N.M., Mishra A., Witte D.P., and Rothenberg M.E. Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma. Am. J. Respir. Cell Mol. Biol. 31 (2004) 257-265
28. Zheng T., Zhu Z., Wang Z., Homer R.J., Ma B., Riese Jr. R.J., Chapman Jr. H.A., Shapiro S.D., and Elias J.A. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J. Clin. Invest. 106 (2000) 1081-1093
29. Lanone S., Zheng T., Zhu Z., Liu W., Lee C.G., Ma B., Chen Q., Homer R.J., Wang J., Rabach L.A., Rabach M.E., Shipley J.M., Shapiro S.D., Senior R.M., and Elias J.A. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J. Clin. Invest. 110 (2002) 463-474
30. Tabata Y., Chen W., Warrier M.R., Gibson A.M., Daines M.O., and Hershey G.K. Allergy-driven alternative splicing of IL-13 receptor alpha2 yields distinct membrane and soluble forms. J. Immunol. 177 (2006) 7905-7912
31. Hawari F.I., Rouhani F.N., Cui X., Yu Z.X., Buckley C., Kaler M., and Levine S.J. Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. Proc. Natl. Acad. Sci. USA 101 (2004) 1297-1302
32. Daines M.O., Tabata Y., Walker B.A., Chen W., Warrier M.R., Basu S., and Hershey G.K. Level of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling. J. Immunol. 176 (2006) 7495-7501